Michelle Miller

Michelle Miller, Ph.D. has extensive experience in the field of scientific research and project management. Michelle is currently working at BioAgilytix as a Scientific Officer and Director. Their previous roles include serving as an Associate Director and Manager at BioAgilytix, where they oversaw bioanalytical operations and managed various projects. Prior to BioAgilytix, Michelle worked at Burleson Research Technologies, Inc. (BRT) as a Study Director and Principal Investigator, where they led immuno-toxicological studies and developed novel assays. Michelle also worked at ScitoVation as an Investigator, retaining responsibilities from their previous organization, The Hamner Institutes for Health Sciences. Michelle's experience also includes roles as a Research Investigator and Postdoctoral Fellow at The Hamner Institutes for Health Sciences, where they conducted research in the field of endocrine disruption. Michelle has also worked as a Postdoctoral Research Scholar at North Carolina State University College of Veterinary Medicine, investigating epigenetic changes during chronic lentiviral infection. Additionally, Michelle has experience as a Laboratory Technician at Tritest Inc, a Research Associate at Pfizer, a Laboratory Assistant at RTI International, a Technical Representative at Nalco, and a Veterinary Assistant at Clayton Animal Hospital.

Michelle Miller, PhD has a Doctor of Philosophy (PhD) in Immunology from North Carolina State University, which was obtained from 2009 to 2013. Michelle also holds a Bachelor of Science (BS) in Zoology and a Bachelor of Arts (BA) in Chemistry from the same university, which were obtained from 2001 to 2006. Furthermore, they have obtained a certification in DABT from the American Board of Toxicology, Inc. in December 2017.